OPAC (Online Public Access Catalog)
Pencarian Koleksi UPA Perpustakaan
start it by typing one or more keywords for title, author or subject
Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Gábor Cserni 1,2 - Personal Name
Cecily Quinn 14 - Personal Name
Inta Liepniece-Karele 13 - Personal Name
Handan Kaya 12 - Personal Name
Janina Kulka 11 - Personal Name
Angelika Reiner 10 - Personal Name
Alicia Cordoba 9 - Personal Name
Anikó Kovács 8 - Personal Name
Davide Balmativola 7 - Personal Name
Isabel Amendoeira 6 - Personal Name
Peter Regitnig 5 - Personal Name
Simonetta Bianchi 4 - Personal Name
Xavier Andreu 3 - Personal Name
Tamás Zombori 2 - Personal Name
Bence Kővári 2 - Personal Name
Tumor draining sentinel lymph nodes (SLNs) are
the sites of selective changes as compared to non-SLNs. They
show features of tumor-reactive lymphadenopathy, including
increased total number of functional blood vessels, but a rel-
ative immunosuppressed status has also been described in
them. We explored the hypothesis of a selective regression
or non-regression in SLNs versus non-SLNs in 142 patients
with 110 estrogen receptor-positive and 32 estrogen receptor-
negative tumors undergoing both SLN biopsy and axillary
lymph node dissection after neoadjuvant therapy by assessing
the tumoral (metastatic) and regression statuses of SLNs and
non-SLNs separately. Of the 89 cases with signs of nodal
regression, 22 cases (25%) were in favor of a selective non-
regression in SLNs, 18 cases (20%) were supportive of a se-
lective and more pronounced regression in the SLNs and the
remaining showed equal degrees of regression or non-
the sites of selective changes as compared to non-SLNs. They
show features of tumor-reactive lymphadenopathy, including
increased total number of functional blood vessels, but a rel-
ative immunosuppressed status has also been described in
them. We explored the hypothesis of a selective regression
or non-regression in SLNs versus non-SLNs in 142 patients
with 110 estrogen receptor-positive and 32 estrogen receptor-
negative tumors undergoing both SLN biopsy and axillary
lymph node dissection after neoadjuvant therapy by assessing
the tumoral (metastatic) and regression statuses of SLNs and
non-SLNs separately. Of the 89 cases with signs of nodal
regression, 22 cases (25%) were in favor of a selective non-
regression in SLNs, 18 cases (20%) were supportive of a se-
lective and more pronounced regression in the SLNs and the
remaining showed equal degrees of regression or non-
Availability
| EB00000002224K | Available |
Detail Information
Series Title
-
Call Number
-
Publisher
: ,
Collation
-
Language
ISBN/ISSN
-
Classification
NONE
Detail Information
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Breast cancer
Sentinel lymph node
Non-sentinel lymph node
Neoadjuvant therapy
Selective regression
Specific Detail Info
-
Statement of Responsibility
-
No other version available
File Attachment
